DNAzyme and rGO based fluorescence assay for Fpg activity analysis, drug screening, and bacterial imaging

Yixing Qiu,Wenya Dang,Jialong Fan,Ting Zhou,Bin Li,Yang Liu,Yan Qin,Chunyi Tong,Muhammad Daniyal,Wei Wang,Bin Liu
DOI: https://doi.org/10.1016/j.talanta.2020.121158
IF: 6.1
2020-10-01
Talanta
Abstract:<p>Due to the significant role of formamidopyrimidine DNA glycosylase (Fpg) in physiological processes and DNA oxidative damage-related diseases, it is essential to establish sensitive methods for monitoring the Fpg activity <em>in vitro</em> and <em>in vivo</em> so as to illustrate its concrete role in these events. In this work, a sensitive, simple and reliable fluorescence assay was developed by taking the advantages of DNAzyme assisted cascade signal amplification and ultra-high fluorescence quenching efficiency of reduced graphene oxide (rGO). This detection system consisted of DNAzyme, rGO and fluorescence probe allows the activity of Fpg to be detected in a linear range from 0 to 80 U/mL with a detection limit of 0.66 U/mL. With the help of this method, 11 natural compounds were screened, and 7 compounds were identified as activators of Fpg. More importantly, the developed assay was used to monitor the activity of Fpg through fluorescence imaging in living <em>Escherichia coli</em> for the first time. The imaging results visually demonstrated the dynamic activation effect of natural compound Ginsenoside Re on the Fpg of <em>Escherichia coli</em>. In summary, these results indicated that this DNAzyme and rGO based fluorescence assay provides a potent strategy for Fpg quantitative assay <em>in vitro</em> and real-time monitoring in living bacteria, which holds great potential for applying on biological study and Fpg-targeted drug screening.</p>
chemistry, analytical
What problem does this paper attempt to address?